Detection of extracellular genomic DNA scaffold in human thrombus: implications for the use of deoxyribonuclease enzymes in thrombolysis.

[1]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[2]  K. Preissner,et al.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases , 2010, Nature Medicine.

[3]  T. Kondo,et al.  Time-dependent organic changes of intravenous thrombi in stasis-induced deep vein thrombosis model and its application to thrombus age determination. , 2010, Forensic science international.

[4]  L. Jensen,et al.  Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  W. Nacken,et al.  Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans , 2009, PLoS pathogens.

[6]  M. Neri,et al.  Histological age determination of venous thrombosis: a neglected forensic task in fatal pulmonary thrombo-embolism. , 2009, Forensic science international.

[7]  E. Medina.  Neutrophil Extracellular Traps: A Strategic Tactic to Defeat Pathogens with Potential Consequences for the Host , 2009, Journal of Innate Immunity.

[8]  T. Kondo,et al.  Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination , 2009, International Journal of Legal Medicine.

[9]  Y. Yeo,et al.  Inhalable Antibiotic Delivery Using a Dry Powder Co-delivering Recombinant Deoxyribonuclease and Ciprofloxacin for Treatment of Cystic Fibrosis , 2009, Pharmaceutical Research.

[10]  E. Bakker,et al.  Pharmacology, clinical efficacy and safety of recombinant human DNase in cystic fibrosis , 2007, Expert review of respiratory medicine.

[11]  M. Watkins,et al.  Hind limb ischemia-reperfusion in the leptin receptor deficient (db/db) mouse. , 2007, The Journal of surgical research.

[12]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[13]  Kyle R. Eberlin,et al.  A novel model of acute murine hindlimb ischemia , 2007 .

[14]  S. Normark,et al.  Neutrophil extracellular traps: casting the NET over pathogenesis. , 2007, Current opinion in microbiology.

[15]  Marc S. Schwartzberg,et al.  Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. , 2006, Journal of vascular and interventional radiology : JVIR.

[16]  W. Earnshaw,et al.  Trashing the genome: the role of nucleases during apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[17]  S. Klebanoff.  Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[18]  M. Watkins,et al.  Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion. , 2005, Archives of surgery.

[19]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[20]  M. Ballmann,et al.  Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis. , 2002, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[21]  J. Arnau,et al.  DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres , 2000, European Journal of Pediatrics.

[22]  G. Seabrook,et al.  Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. , 1999, Radiology.

[23]  J. Calvert,et al.  Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Scottish Cystic Fibrosis Group. , 1999, The European respiratory journal.

[24]  H. Fuchs,et al.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.

[25]  M. Monestier,et al.  Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. , 1992, Journal of immunology.

[26]  J. Navarro,et al.  Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. , 1989, Thrombosis research.